INSIGHTS ON CRITICAL ENVIRONMENTS
-
cGMP Vs GMP In Cleanrooms: Understanding The Differences That Matter
Differentiating GMP from cGMP helps facility teams design cleanrooms that meet modern contamination controls, process flows, and regulatory standards.
-
At-A-Glance Monitoring: Inside The TSI FMS Web Client Dashboard
Understand your environment quickly with real-time, customizable data and interactive controls, whether you manage a single site or multiple locations.
-
Sustainability, Corporate Social Responsibility In Capital Equipment Purchasing And Asset Management
Learn how pharmaceutical companies can reduce waste, cut emissions, and improve financial performance by prioritizing equipment reuse and optimizing asset management.
-
Bioprocessing Equipment And Automation Product Portfolio Overview
Accelerate biotherapeutic development with innovative bioprocessing equipment and automation solutions that feature single-use mixers, bioreactors, and more to streamline workflows and speed products to market.
-
Product Carbon Footprints: The Next Frontier In Sustainable Innovation12/12/2025
Product Carbon Footprints reveal true lifecycle emissions, enabling collaboration, innovation, and informed decisions. Learn why moving from estimates to evidence is essential for reducing Scope 3 impact.
-
From Process Monitoring To Manufacturing Intelligence: Real-Time Analytics And Predictive Control In Biomanufacturing6/19/2026
Advanced analytics, predictive modeling, explainable AI, and digital twins are helping biomanufacturers improve process visibility, anticipate outcomes, and support smarter operational decisions.
-
Environmental Monitoring In Advanced Therapeutic Medicinal Products Facilities3/5/2026
Discover how to adapt your environmental monitoring framework to meet the distinct risk-management and regulatory needs of ATMP facility production.
-
Biofluorescent Particle Counters Are Gaining Momentum4/28/2025
The 2025 BioPhorum report highlights challenges and trends in drug filling operations and how they are advancing towards biofluorescent particle counters. Discover an approach that aligns with industry needs.
-
503A Vs. 503B: Turning Regulatory Complexity Into Practical Compliance4/20/2026
Navigating human drug compounding requires aligning Section 503A and Section 503B operations with cGMP expectations, robust quality management systems, and standing inspection readiness.
CRITICAL ENVIRONMENT SOLUTIONS
-
AES is the only USA-based firm that designs, manufactures, and installs modular cleanroom facilities. You can rest assured that your project will be built on time and on budget. Our expertise in cleanrooms, combined with our singular focus on your success is second to none.
-
Restricted Access Barriers (RABs) were developed to enhance pharmaceutical aseptic processes carried out in conventional clean rooms. Extract Technology customer RABs are designed to fully comply with our customers’ requirements for aseptic pharmaceutical processing.
-
Available Immediately
Turnkey Contract Pharmaceutical Operation Available Immediately. Manufacturing OTC Sprays, Liquids, Creams, Aerosols, Gels, Inhalers, & More!
-
FMS/BioTrak/Portable/Remote/Environmental Sensors
-
Speed-to-market is the number one driver in the pharma/bio industry today ... the faster our clients can build facilities, the quicker they can get treatments into the hands of the patients who need them the most. The AES Fast Lane program is an accelerated Design, Manufacture, and Installation program that fast tracks your cleanroom facility project in seven months.
FREE CLEANING VALIDATION E-BOOK
Learn how to employ science-, risk-, and statistics-based approaches to cleaning and cleaning validation at your facility with this free, 100-page e-book, written by a global team of cleaning validation experts, pharmaceutical toxicologists, statisticians, and Six Sigma professionals.
